Cargando…

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a polymorphic, multisystemic autoimmune disease that causes multiorgan damage in which cellular communication occurs through the involvement of autoantibodies directed against autoantigen production. Mesenchymal stem cells (MSCs), which have strong protective an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Tianbiao, Li, Hong-Yan, Liao, Chunling, Lin, Wenshan, Lin, Shujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157802/ https://www.ncbi.nlm.nih.gov/pubmed/32322279 http://dx.doi.org/10.1155/2020/6518508

Ejemplares similares

Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants
por: Lin, Shujun, et al.
Publicado: (2020)

The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
por: Zhou, Tianbiao, et al.
Publicado: (2019)

Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis
por: Lin, Wenshan, et al.
Publicado: (2021)

Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population
por: Lin, Shujun, et al.
Publicado: (2019)

Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis
por: Lin, Wenshan, et al.
Publicado: (2019)

An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus
por: Yang, Qian, et al.
Publicado: (2021)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Relationship between TGF-β1 + 869 T/C and + 915 G/C gene polymorphism and risk of acute rejection in renal transplantation recipients
por: Li, Hong-Yan, et al.
Publicado: (2019)

Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus
por: Yao, Kaijin, et al.
Publicado: (2023)

Association of hypoxia-inducible factor-1α (HIF1α) 1790G/A gene polymorphism with renal cell carcinoma and prostate cancer susceptibility: a meta-analysis
por: Li, Hong-Yan, et al.
Publicado: (2019)

Clinical efficacy and safety of sirolimus in childhood-onset systemic lupus erythematosus in real world
por: Zhang, Lei, et al.
Publicado: (2022)

Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus
por: Eriksson, Per, et al.
Publicado: (2019)

Relationship of anifrolumab pharmacokinetics with efficacy and safety in patients with systemic lupus erythematosus
por: Chia, Yen Lin, et al.
Publicado: (2021)

Potential Therapeutic Effect and Mechanisms of Mesenchymal Stem Cells-Extracellular Vesicles in Renal Fibrosis
por: Liao, Chunling, et al.
Publicado: (2022)

All-trans retinoic acid regulating angiopoietins-1 and alleviating extracellular matrix accumulation in interstitial fibrosis rats
por: Zhong, Zhiqing, et al.
Publicado: (2021)

Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus
por: Zhu, Yantong, et al.
Publicado: (2018)

Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus
por: Li, Aifen, et al.
Publicado: (2021)

Efficacy and safety of rituximab for systemic lupus erythematosus treatment: a meta-analysis
por: Wu, Shanshan, et al.
Publicado: (2020)

Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
por: Chan, Justin, et al.
Publicado: (2023)

Efficacy and safety of belimumab/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus
por: Cheng, Hao, et al.
Publicado: (2022)

Improved therapeutic consistency and efficacy of mesenchymal stem cells expanded with chemically defined medium for systemic lupus erythematosus
por: Xu, Jianyong, et al.
Publicado: (2020)

Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus
por: Cortés-Hernández, Josefina, et al.
Publicado: (2012)

Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis
por: Peng, Liying, et al.
Publicado: (2020)

Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells
por: Wen, Lihui, et al.
Publicado: (2019)

Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus
por: Miyazaki, Yusuke, et al.
Publicado: (2021)

The Safety and Efficacy of Rituximab and Belimumab in Systemic Lupus Erythematosus: A Systematic Review
por: Abid, Naushad, et al.
Publicado: (2023)

Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety
por: Téllez Arévalo, Angélica María, et al.
Publicado: (2022)

Meta-analysis of associations of vascular endothelial growth factor protein levels and -634G/C polymorphism with systemic lupus erythematosus susceptibility
por: Tang, Wenzhuang, et al.
Publicado: (2019)

Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis
por: Zhong, Hongzhen, et al.
Publicado: (2020)

The safety and efficacy of biologic agents in treatment of systemic lupus erythematosus: A network meta-analysis
por: Tao, Meng-Jun, et al.
Publicado: (2019)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs
por: Yao, Genhong, et al.
Publicado: (2022)

Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus
por: Schwarting, A, et al.
Publicado: (2016)

Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose
por: Wakiya, Risa, et al.
Publicado: (2020)

Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus
por: Chen, Xiaotong, et al.
Publicado: (2023)

Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancy
por: Zhang, Fen, et al.
Publicado: (2023)

Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study
por: Jin, Hui-Zhi, et al.
Publicado: (2023)

Association of Nuclear Receptor Coactivators with Hypoxia-Inducible Factor-1α in the Serum of Patients with Chronic Kidney Disease
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b2k4bkalqpb2ig31858crdg4a4